The Potential for Natural Products to Overcome Cancer Drug Resistance by Modulation of Epithelial-Mesenchymal Transition

被引:3
|
作者
Ghalehno, Asefeh Dahmardeh [1 ]
Boustan, Arad [2 ]
Abdi, Hakimeh [1 ]
Aganj, Zahra [1 ]
Mosaffa, Fatemeh [3 ]
Jamialahmadi, Khadijeh [3 ]
机构
[1] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Mashhad, Razavi Khorasan, Iran
[2] Mashhad Univ Med Sci, Fac Med, Dept Med Biotechnol & Nanotechnol, Mashhad 8564917794, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Biotechnol Res Ctr, Pharmaceut Technol Inst, Mashhad, Razavi Khorasan, Iran
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2022年 / 74卷 / 08期
关键词
CELL LUNG-CANCER; PIEN TZE HUANG; NF-KAPPA-B; HYPOXIA-INDUCIBLE FACTOR; WNT SIGNALING PATHWAYS; COLON-CARCINOMA CELLS; E-CADHERIN EXPRESSION; D INDUCES APOPTOSIS; BREAST-CANCER; COLORECTAL-CANCER;
D O I
10.1080/01635581.2021.2022169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The acquisition of resistance and ultimately disease relapse after initial response to chemotherapy put obstacles in the way of cancer therapy. Epithelial-mesenchymal transition (EMT) is a biologic process that epithelial cells alter to mesenchymal cells and acquire fibroblast-like properties. EMT plays a significant role in cancer metastasis, motility, and survival. Recently, emerging evidence suggested that EMT pathways are very important in making drug-resistant involved in cancer. Natural products are gradually emerging as a valuable source of safe and effective anticancer compounds. Natural products could interfere with the different processes implicated in cancer drug resistance by reversing the EMT process. In this review, we illustrate the molecular mechanisms of EMT in the emergence of cancer metastasis. We then present the role of natural compounds in the suppression of EMT pathways in different cancers to overcome cancer cell drug resistance and improve tumor chemotherapy.
引用
收藏
页码:2686 / 2712
页数:27
相关论文
共 50 条
  • [1] Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
    Du, Bowen
    Shim, Joong Sup
    MOLECULES, 2016, 21 (07):
  • [2] Epithelial-mesenchymal transition and drug resistance in breast cancer
    Huang, Jing
    Li, Hongzhong
    Ren, Guosheng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 840 - 848
  • [3] Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
    Shang, Yulong
    Cai, Xiqiang
    Fan, Daiming
    CURRENT CANCER DRUG TARGETS, 2013, 13 (09) : 915 - 929
  • [4] Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic
    Voulgari, Angeliki
    Pintzas, Alexander
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2009, 1796 (02): : 75 - 90
  • [5] The importance of epithelial-mesenchymal transition and autophagy in cancer drug resistance
    Hill, Charlotte
    Wang, Yihua
    CANCER DRUG RESISTANCE, 2020, 3 (01) : 38 - 47
  • [6] Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
    Zhang, Haiyun
    Steed, Alexander
    Co, Milo
    Chen, Xiaozhuo
    CANCER DRUG RESISTANCE, 2021, 4 (03) : 684 - 709
  • [7] Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer
    Ni, Qianyang
    Li, Meng
    Yu, Suyang
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [8] Epithelial-mesenchymal transition as a potential route for DAPT resistance in breast cancer cells
    Telli, Kubra
    Yalcin-Ozuysal, Ozden
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2023, 48 (01): : 88 - 95
  • [9] The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer
    Ginnebaugh, Kevin R.
    Ahmad, Aamir
    Sarkar, Fazlul H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (07) : 731 - 745
  • [10] The relationship between platinum drug resistance and epithelial-mesenchymal transition
    Brozovic, Anamaria
    ARCHIVES OF TOXICOLOGY, 2017, 91 (02) : 605 - 619